* Sabra Health Care REIT Inc SBRA.OQ SBRA.O is expected
to show a rise in quarterly revenue when it reports results
* The Irvine California-based company is expected to report
a
12.9% increase in revenue to $158.954 million from $140.76
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data.
* Refinitiv's mean analyst estimate for Sabra Health Care
REIT
Inc is for earnings of 13 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 8
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sabra
Health Care
REIT Inc is $14.5, above its last closing price of $14.23.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.33 0.33 0.33 Met -1.3
Mar. 31 2023 0.34 0.34 0.33 Missed -4
Dec. 31 2022 0.35 0.36 0.37 Beat 4.1
Sep. 30 2022 0.37 0.37 0.36 Missed -3.2
Jun. 0.38 0.38 0.39 Beat 3.6
30 2022
Mar. 31 2022 0.38 0.38 0.38 Met -0.7
Dec. 31 2021 0.36 0.37 0.39 Beat 5.7
Sep. 30 2021 0.39 0.39 0.38 Missed -2.2
This summary was machine generated November 3 at 00:03 GMT. All
figures in US dollars unless otherwise stated